In-licensing

Delivery technologies for oral, topical and transdermal products which could be applicable to the consumer healthcare arena More

OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More

APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration More

A global OTC drug products group with offices in the UK is seeking orally delivered modified release drug delivery systems that extend the efficacy of active pharmaceutical ingredients (APIs), which are susceptible to a large first-pass metabolism. More

A global OTC Pharma products group is seeking technologies, approaches and materials that are able to prolong adhesion to a mucosal surface of the oral, pharyngeal, throat, nasal and upper & lower respiratory tracts. More

A Global healthcare company is currently seeking technologies to modify the solubility characteristics of liquid formulations, containing active ingredients. More